STOCK TITAN

Westlake Chem Partners Lp Financials

WLKP
Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Westlake Chem Partners Lp (WLKP) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI WLKP FY2025

This is a cash-harvesting business: operating cash flow routinely exceeds accounting profit, while most excess cash is paid back out.

In FY2025, operating cash flow of $280M still far exceeded net income of $49M, extending a multi-year pattern of unusually strong cash conversion. Even after just $79M of capex, year-end cash was only $44M, which implies the business is structured to release cash from a mature asset base rather than retain much of it on the balance sheet.

FY2025 shows margin compression inside a mostly steady revenue base: sales were $1.17B while free-cash-flow margin fell to 17.3%. After reaching 38.4% in FY2024, that drop suggests annual cash yield is highly sensitive to margin and cash-timing swings even when the top line is relatively stable.

Inventory of only $2.8M against revenue of $1.17B implies a light working-capital footprint, so little cash is trapped in stock. With total liabilities at $454M versus assets of $1.26B, the balance sheet still looks liquid and absorbent enough to handle a softer operating year without obvious short-term strain.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity Cash Flow Returns 73 / 100
Financial Health Score 73/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Westlake Chem Partners Lp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
91

Westlake Chem Partners Lp has an operating margin of 27.4%, meaning the company retains $27 of operating profit per $100 of revenue. This strong profitability earns a score of 91/100, reflecting efficient cost management and pricing power. This is down from 34.4% the prior year.

Growth
29

Westlake Chem Partners Lp's revenue grew a modest 2.7% year-over-year to $1.2B. This slow but positive growth earns a score of 29/100.

Leverage
57

Westlake Chem Partners Lp has a moderate D/E ratio of 0.57. This balance of debt and equity financing earns a leverage score of 57/100.

Liquidity
74

With a current ratio of 2.80, Westlake Chem Partners Lp holds $2.80 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 74/100.

Cash Flow
93

Westlake Chem Partners Lp converts 17.3% of revenue into free cash flow ($201.7M). This strong cash generation earns a score of 93/100.

Returns
96

Westlake Chem Partners Lp earns a strong 6.1% return on equity (ROE), meaning it generates $6 of profit for every $100 of shareholders' equity. This efficient capital use earns a returns score of 96/100. This is down from 7.5% the prior year.

Piotroski F-Score Partial
4/7

Westlake Chem Partners Lp passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 3 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
5.76x

For every $1 of reported earnings, Westlake Chem Partners Lp generates $5.76 in operating cash flow ($280.5M OCF vs $48.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe
14.0x

Westlake Chem Partners Lp earns $14.0 in operating income for every $1 of interest expense ($319.6M vs $22.9M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$1.2B
YoY+2.7%
5Y CAGR+3.8%
10Y CAGR+1.5%

Westlake Chem Partners Lp generated $1.2B in revenue in fiscal year 2025. This represents an increase of 2.7% from the prior year.

EBITDA
$447.6M
YoY-10.9%
5Y CAGR-0.4%
10Y CAGR+0.2%

Westlake Chem Partners Lp's EBITDA was $447.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 10.9% from the prior year.

Net Income
$48.7M
YoY-21.9%
5Y CAGR-5.9%
10Y CAGR+2.0%

Westlake Chem Partners Lp reported $48.7M in net income in fiscal year 2025. This represents a decrease of 21.9% from the prior year.

EPS (Diluted)
N/A

Cash & Balance Sheet

Free Cash Flow
$201.7M
YoY-53.8%
5Y CAGR-9.7%
10Y CAGR-0.9%

Westlake Chem Partners Lp generated $201.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 53.8% from the prior year.

Cash & Debt
$44.3M
YoY-24.1%
5Y CAGR+20.9%
10Y CAGR-12.6%

Westlake Chem Partners Lp held $44.3M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share
N/A
Shares Outstanding
N/A

Margins & Returns

Gross Margin
29.8%
YoY-7.1pp
5Y CAGR-9.4pp
10Y CAGR-8.2pp

Westlake Chem Partners Lp's gross margin was 29.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 7.1 percentage points from the prior year.

Operating Margin
27.4%
YoY-7.0pp
5Y CAGR-9.1pp
10Y CAGR-8.3pp

Westlake Chem Partners Lp's operating margin was 27.4% in fiscal year 2025, reflecting core business profitability. This is down 7.0 percentage points from the prior year.

Net Margin
4.2%
YoY-1.3pp
5Y CAGR-2.7pp
10Y CAGR+0.2pp

Westlake Chem Partners Lp's net profit margin was 4.2% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1.3 percentage points from the prior year.

Return on Equity
6.1%
YoY-1.5pp
5Y CAGR-1.2pp
10Y CAGR+1.4pp

Westlake Chem Partners Lp's ROE was 6.1% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 1.5 percentage points from the prior year.

Capital Allocation

R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
$78.8M
YoY+60.9%
5Y CAGR+16.3%
10Y CAGR-10.2%

Westlake Chem Partners Lp invested $78.8M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 60.9% from the prior year.

WLKP Income Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Revenue $305.7M-5.4% $323.0M+4.6% $308.9M+4.0% $297.1M+25.0% $237.6M-18.1% $290.1M+4.7% $277.0M-2.5% $284.2M
Cost of Revenue $211.9M-6.3% $226.2M+8.0% $209.5M+5.0% $199.6M+8.7% $183.5M-4.1% $191.5M+19.6% $160.1M-12.5% $182.9M
Gross Profit $93.8M-3.2% $96.8M-2.6% $99.4M+1.9% $97.5M+80.3% $54.1M-45.1% $98.6M-15.7% $116.9M+15.5% $101.2M
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $7.2M+1.9% $7.1M-5.3% $7.4M+18.2% $6.3M-15.7% $7.5M+14.0% $6.6M-9.6% $7.3M-4.6% $7.6M
Operating Income $86.6M-3.6% $89.8M-2.4% $92.0M+0.8% $91.2M+95.7% $46.6M-49.4% $92.0M-16.1% $109.7M+17.2% $93.6M
Interest Expense $5.1M-7.7% $5.5M-7.4% $5.9M+0.7% $5.9M+6.7% $5.5M-4.1% $5.8M-13.8% $6.7M+0.7% $6.7M
Income Tax $177K-8.3% $193K+359.5% $42K-79.5% $205K+91.6% $107K-47.0% $202K-6.5% $216K+4.3% $207K
Net Income $14.2M-2.5% $14.5M-0.8% $14.7M+0.7% $14.6M+194.2% $4.9M-67.0% $15.0M-17.3% $18.1M+25.7% $14.4M
EPS (Diluted) N/A N/A N/A N/A N/A N/A N/A N/A

WLKP Balance Sheet

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Total Assets $1.2B-1.7% $1.3B-1.2% $1.3B-2.7% $1.3B-4.7% $1.4B+6.5% $1.3B-0.5% $1.3B+0.5% $1.3B
Current Assets $148.9M+3.8% $143.5M+9.7% $130.9M-16.4% $156.5M-30.5% $225.2M-6.5% $240.9M-0.3% $241.6M+4.1% $232.1M
Cash & Equivalents $44.3M0.0% $44.3M+16.7% $37.9M+3.7% $36.6M-26.3% $49.6M-14.9% $58.3M-3.1% $60.2M-8.8% $66.0M
Inventory $3.1M+11.7% $2.8M-10.0% $3.1M-5.6% $3.3M+19.3% $2.7M-32.7% $4.1M+8.2% $3.8M-16.4% $4.5M
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill $5.8M0.0% $5.8M0.0% $5.8M0.0% $5.8M0.0% $5.8M0.0% $5.8M0.0% $5.8M0.0% $5.8M
Total Liabilities $443.3M-2.4% $454.2M-0.9% $458.3M-3.7% $476.0M-16.2% $568.2M+23.9% $458.6M+0.4% $456.9M+0.7% $453.5M
Current Liabilities $40.8M-20.5% $51.3M-6.9% $55.1M-24.4% $72.9M-55.8% $164.8M+197.7% $55.4M+3.9% $53.3M+7.4% $49.6M
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity $792.4M-1.2% $802.4M-1.3% $813.3M-2.1% $831.2M+3.5% $803.1M-3.2% $829.3M-1.0% $837.8M+0.4% $834.8M
Retained Earnings N/A N/A N/A N/A N/A N/A N/A N/A

WLKP Cash Flow Statement

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Operating Cash Flow $110.2M-8.5% $120.4M+14.4% $105.2M+1060.2% $9.1M-80.2% $45.8M-65.4% $132.5M+5.1% $126.1M+3.4% $121.9M
Capital Expenditures $5.6M-37.1% $8.8M-70.2% $29.7M+21.6% $24.4M+52.8% $16.0M+18.4% $13.5M-13.3% $15.5M+52.7% $10.2M
Free Cash Flow $104.6M-6.2% $111.5M+47.6% $75.6M+593.7% -$15.3M-151.3% $29.8M-74.9% $119.0M+7.7% $110.5M-1.1% $111.7M
Investing Cash Flow -$18.6M+1.4% -$18.8M-5510.6% $348K-99.0% $35.6M+153.6% $14.0M+136.5% -$38.5M-26.0% -$30.5M-200.1% -$10.2M
Financing Cash Flow -$91.6M+3.8% -$95.2M+8.6% -$104.2M-80.5% -$57.7M+15.7% -$68.5M+28.5% -$95.9M+5.4% -$101.3M+0.2% -$101.5M
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

WLKP Financial Ratios

Metric Q1'26 Q4'25 Q3'25 Q2'25 Q1'25 Q4'24 Q3'24 Q2'24
Gross Margin 30.7%+0.7pp 30.0%-2.2pp 32.2%-0.6pp 32.8%+10.1pp 22.8%-11.2pp 34.0%-8.2pp 42.2%+6.6pp 35.6%
Operating Margin 28.3%+0.5pp 27.8%-2.0pp 29.8%-0.9pp 30.7%+11.1pp 19.6%-12.1pp 31.7%-7.9pp 39.6%+6.7pp 33.0%
Net Margin 4.6%+0.1pp 4.5%-0.2pp 4.7%-0.2pp 4.9%+2.8pp 2.1%-3.1pp 5.2%-1.4pp 6.6%+1.5pp 5.1%
Return on Equity 1.8%-0.0pp 1.8%+0.0pp 1.8%+0.0pp 1.8%+1.1pp 0.6%-1.2pp 1.8%-0.3pp 2.2%+0.4pp 1.7%
Return on Assets 1.1%0.0pp 1.2%0.0pp 1.1%+0.0pp 1.1%+0.8pp 0.4%-0.8pp 1.2%-0.2pp 1.4%+0.3pp 1.1%
Current Ratio 3.65+0.9 2.80+0.4 2.37+0.2 2.15+0.8 1.37-3.0 4.35-0.2 4.53-0.1 4.68
Debt-to-Equity 0.560.0 0.570.0 0.560.0 0.57-0.1 0.71+0.2 0.550.0 0.550.0 0.54
FCF Margin 34.2%-0.3pp 34.5%+10.1pp 24.5%+29.6pp -5.1%-17.7pp 12.6%-28.5pp 41.0%+1.1pp 39.9%+0.6pp 39.3%

Similar Companies

Frequently Asked Questions

Westlake Chem Partners Lp (WLKP) reported $1.2B in total revenue for fiscal year 2025. This represents a 2.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Westlake Chem Partners Lp (WLKP) revenue grew by 2.7% year-over-year, from $1.1B to $1.2B in fiscal year 2025.

Yes, Westlake Chem Partners Lp (WLKP) reported a net income of $48.7M in fiscal year 2025, with a net profit margin of 4.2%.

Westlake Chem Partners Lp (WLKP) had EBITDA of $447.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

Westlake Chem Partners Lp (WLKP) had a gross margin of 29.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Westlake Chem Partners Lp (WLKP) had an operating margin of 27.4% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Westlake Chem Partners Lp (WLKP) had a net profit margin of 4.2% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Westlake Chem Partners Lp (WLKP) has a return on equity of 6.1% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Westlake Chem Partners Lp (WLKP) generated $201.7M in free cash flow during fiscal year 2025. This represents a -53.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Westlake Chem Partners Lp (WLKP) generated $280.5M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Westlake Chem Partners Lp (WLKP) had $1.3B in total assets as of fiscal year 2025, including both current and long-term assets.

Westlake Chem Partners Lp (WLKP) invested $78.8M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Westlake Chem Partners Lp (WLKP) had a current ratio of 2.80 as of fiscal year 2025, which is generally considered healthy.

Westlake Chem Partners Lp (WLKP) had a debt-to-equity ratio of 0.57 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Westlake Chem Partners Lp (WLKP) had a return on assets of 3.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Westlake Chem Partners Lp (WLKP) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Westlake Chem Partners Lp (WLKP) has an earnings quality ratio of 5.76x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Westlake Chem Partners Lp (WLKP) has an interest coverage ratio of 14.0x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Westlake Chem Partners Lp (WLKP) scores 73 out of 100 on our Financial Health Score, indicating strong standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top